{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:58:36Z","timestamp":1789077516966,"version":"build-2803163510"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"SERB-Department of Science & Technology (SERB-DST), Government of India","award":["SB\/S2\/RJN-087\/2014"],"award-info":[{"award-number":["SB\/S2\/RJN-087\/2014"]}]},{"name":"CSIR\/UGC JRF","award":["21\/06\/2015(i)"],"award-info":[{"award-number":["21\/06\/2015(i)"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.yexcr.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T14:31:34Z","timestamp":1508855494000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells \u2013 An updated review"],"prefix":"10.1016","volume":"362","author":[{"given":"Thingreila","family":"Muinao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari Prasanna","family":"Deka Boruah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintu","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.yexcr.2017.10.018_bib1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/ncponc0287","article-title":"Primer: an evidence-based approach to prognostic markers","volume":"2","author":"Altman","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"Alvero","year":"2009","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PGP.0b013e3181f45f3e","article-title":"The origin of ovarian carcinomas: a unifying hypothesis","volume":"30","author":"Auersperg","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/PGP.0b013e3182800ad5","article-title":"The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae","volume":"32","author":"Auersperg","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00404-013-2722-2","article-title":"Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?","volume":"288","author":"Azzam","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ygyno.2007.04.022","article-title":"Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment","volume":"106","author":"Badgwell","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"15","key":"10.1016\/j.yexcr.2017.10.018_bib7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ygyno.2005.08.035","article-title":"Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival","volume":"100","author":"Beeghly","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.yexcr.2017.10.018_bib9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrc1474","article-title":"The emerging roles of human tissue kallikreins in cancer","volume":"4","author":"Borgono","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.yexcr.2017.10.018_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q","article-title":"Benign conditions associated with raised serum CA-125 concentration","volume":"75","author":"Buamah","year":"2000","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jso.2930560204","article-title":"Serum CA 125 concentrations in patients with benign ovarian tumours","volume":"56","author":"Buamah","year":"1994","journal-title":"J. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.yexcr.2017.10.018_bib12","first-page":"996","article-title":"Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes","volume":"22","author":"Cannistra","year":"1994","journal-title":"Exp. Hematol."},{"issue":"20","key":"10.1016\/j.yexcr.2017.10.018_bib13","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/onc.2011.429","article-title":"Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer","volume":"31","author":"Cao","year":"2012","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.yexcr.2017.10.018_bib14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/modpathol.2009.35","article-title":"ALDH1 expression correlates with favorable prognosis in ovarian cancers","volume":"22","author":"Chang","year":"2009","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib15","first-page":"1277","article-title":"Increased expression of miR-148b in ovarian carcinoma and its clinical significance","volume":"5","author":"Chang","year":"2012","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/BJ20110282","article-title":"Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK\/ERK and JNK pathways","volume":"442","author":"Chang","year":"2012","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.yexcr.2017.10.018_bib17","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.bbamcr.2007.04.013","article-title":"Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3","volume":"1773","author":"Chen","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.molonc.2011.11.010","article-title":"Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response","volume":"6","author":"Chen","year":"2012","journal-title":"Mol. Oncol."},{"issue":"9","key":"10.1016\/j.yexcr.2017.10.018_bib19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/IGC.0b013e3181ad0fa2","article-title":"B7-H4 expression promotes tumorigenesis in ovarian cancer","volume":"19","author":"Cheng","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.yexcr.2017.10.018_bib20","doi-asserted-by":"crossref","first-page":"10357","DOI":"10.1038\/srep10357","article-title":"Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer","volume":"5","author":"Cioffi","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ygyno.2011.06.002","article-title":"Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer","volume":"122","author":"Clarke","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.yexcr.2017.10.018_bib22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2006.03.011","article-title":"Stem cells and cancer: two faces of eve","volume":"124","author":"Clarke","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/172460080001500204","article-title":"Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer","volume":"15","author":"Colakovic","year":"2000","journal-title":"Int. J. Biol. Mark."},{"issue":"6","key":"10.1016\/j.yexcr.2017.10.018_bib25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/bjc.2011.34","article-title":"Downregulation of cell surface CA125\/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells","volume":"104","author":"Comamala","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.yexcr.2017.10.018_bib26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1590\/S1807-59322009000700006","article-title":"Prostasin, a potential tumor marker in ovarian cancer \u2013 a pilot study","volume":"64","author":"Costa","year":"2009","journal-title":"Clinics"},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2006.10.063","article-title":"Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma","volume":"105","author":"Dainty","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.yexcr.2017.10.018_bib28","doi-asserted-by":"crossref","first-page":"e10277","DOI":"10.1371\/journal.pone.0010277","article-title":"Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers","volume":"5","author":"Deng","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.yexcr.2017.10.018_bib29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.clinbiochem.2004.04.009","article-title":"Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients","volume":"37","author":"Diamandis","year":"2004","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.yexcr.2017.10.018_bib30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1200\/JCO.2003.02.022","article-title":"Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma","volume":"21","author":"Diamandis","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.yexcr.2017.10.018_bib31","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/sj.bjc.6605906","article-title":"Role of human tissue kallikrein in gastrointestinal stromal tumour invasion","volume":"103","author":"Dominek","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib32","first-page":"1710","article-title":"Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers","volume":"9","author":"Dong","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.yexcr.2017.10.018_bib33","first-page":"2363","article-title":"Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas","volume":"7","author":"Dong","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.yexcr.2017.10.018_bib34","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.yexcr.2017.10.018_bib35","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2004.09.112","article-title":"Early\u00a0detection and\u00a0prognosis\u00a0of\u00a0ovarian\u00a0cancer\u00a0using\u00a0serum\u00a0YKL-40","volume":"22","author":"Dupont","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib36","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1525-1438.2007.01056.x","article-title":"Expression of CD133-1 and CD133-2 in ovarian cancer","volume":"18","author":"Ferrandina","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.yexcr.2017.10.018_bib37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1008247428385","article-title":"Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome","volume":"8","author":"Ferrandina","year":"1997","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejogrb.2004.02.045","article-title":"Serum lipids concentration in women with benign and malignant ovarian tumours","volume":"120","author":"Gadomska","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"18","key":"10.1016\/j.yexcr.2017.10.018_bib39","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"Gao","year":"2010","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib40","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/REP-14-0234","article-title":"Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm","volume":"149","author":"Garson","year":"2015","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2015.1121348","article-title":"The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells","volume":"17","author":"Gawlik-Rzemieniewska","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2017.10.018_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2407-5-133","article-title":"Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients","volume":"5","author":"Gericke","year":"2005","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.yexcr.2017.10.018_bib44","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI23412","article-title":"Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer","volume":"115","author":"Glinsky","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.yexcr.2017.10.018_bib45","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mc.22340","article-title":"Regulation of NANOG in cancer cells","volume":"54","author":"Gong","year":"2015","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2010.03.013","article-title":"Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms","volume":"296","author":"Hellstrom","year":"2010","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/GCO.0b013e3282f2b124","article-title":"Cancer antigen 125 and prognosis","volume":"20","author":"Hogdall","year":"2008","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.yexcr.2017.10.018_bib48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bjc.6602719","article-title":"The Notch pathway in ovarian carcinomas and adenomas","volume":"93","author":"Hopfer","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.yexcr.2017.10.018_bib49","first-page":"2439","article-title":"Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer","volume":"4","author":"Howells","year":"1998","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.yexcr.2017.10.018_bib50","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.bjc.6605626","article-title":"Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant","volume":"102","author":"Hu","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2009.05.022","article-title":"A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer","volume":"114","author":"Hu","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2017.10.018_bib52","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12885-015-1513-5","article-title":"The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study","volume":"15","author":"Huang","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2017.10.018_bib53","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.nu.14.070194.002431","article-title":"Transthyretin (prealbumin) in health and disease: nutritional implications","volume":"14","author":"Ingenbleek","year":"1994","journal-title":"Annu. Rev. Nutr."},{"issue":"18","key":"10.1016\/j.yexcr.2017.10.018_bib54","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer","volume":"67","author":"Iorio","year":"2007","journal-title":"Cancer Res."},{"issue":"6715","key":"10.1016\/j.yexcr.2017.10.018_bib55","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/16476","article-title":"The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus","volume":"397","author":"Jacobs","year":"1999","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.yexcr.2017.10.018_bib56","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1101\/gad.13.20.2678","article-title":"Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a\/ARF","volume":"13","author":"Jacobs","year":"1999","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.yexcr.2017.10.018_bib57","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.294.10.1255","article-title":"Trends in the leading causes of death in the United States, 1970\u20132002","volume":"294","author":"Jemal","year":"2005","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.yexcr.2017.10.018_bib59","doi-asserted-by":"crossref","first-page":"14806","DOI":"10.18632\/oncotarget.14775","article-title":"hPaf1\/PD2 interacts with OCT3\/4 to promote self-renewal of ovarian cancer stem cells","volume":"8","author":"Karmakar","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.21712","article-title":"The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?","volume":"119","author":"Kelemen","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"13","key":"10.1016\/j.yexcr.2017.10.018_bib61","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.287.13.1671","article-title":"Osteopontin as a potential diagnostic biomarker for ovarian cancer","volume":"287","author":"Kim","year":"2002","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cll.2009.02.001","article-title":"Development and validation of a protein-based signature for the detection of ovarian cancer","volume":"29","author":"Kim","year":"2009","journal-title":"Clin. Lab. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib63","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2015.05.009","article-title":"Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-alpha and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer","volume":"138","author":"Kolomeyevskaya","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.yexcr.2017.10.018_bib64","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0002-9440(10)64398-2","article-title":"CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival","volume":"161","author":"Kristiansen","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.25967","article-title":"Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells","volume":"130","author":"Kryczek","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib66","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ijc.2910520302","article-title":"Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian disease","volume":"52","author":"Kuesel","year":"1992","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.yexcr.2017.10.018_bib67","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1074\/mcp.M800516-MCP200","article-title":"Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system","volume":"8","author":"Kuzmanov","year":"2009","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.yexcr.2017.10.018_bib68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2407-11-210","article-title":"Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients","volume":"11","author":"Lane","year":"2011","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.yexcr.2017.10.018_bib69","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1515\/CCLM.2002.227","article-title":"Protein status in pancreatitis--transthyretin is a sensitive biomarker of malnutrition in acute and chronic pancreatitis","volume":"40","author":"Lasztity","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"issue":"8","key":"10.1016\/j.yexcr.2017.10.018_bib70","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1701-2163(16)32914-0","article-title":"Importance of CA125 normalization during neoadjuvant chemotherapy followed by planned delayed surgical debulking in patients with epithelial ovarian cancer","volume":"30","author":"Le","year":"2008","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib71","first-page":"1149","article-title":"CD24 overexpression in cancer development and progression: a meta-analysis","volume":"22","author":"Lee","year":"2009","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ygyno.2010.06.004","article-title":"MiR-27a modulates MDR1\/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells","volume":"119","author":"Li","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib73","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ygyno.2015.03.044","article-title":"Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: clinical correlates","volume":"137","author":"Liao","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.yexcr.2017.10.018_bib74","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.humpath.2012.12.016","article-title":"Aldehyde dehydrogenase 1\/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma","volume":"44","author":"Liebscher","year":"2013","journal-title":"Hum. Pathol."},{"issue":"7","key":"10.1016\/j.yexcr.2017.10.018_bib75","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1007\/s13277-016-4848-x","article-title":"NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer","volume":"l37","author":"Liu","year":"2016","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib76","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2005.12.011","article-title":"Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer","volume":"102","author":"Lokshin","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.yexcr.2017.10.018_bib77","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/omi.2013.0058","article-title":"SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention","volume":"17","author":"Lou","year":"2013","journal-title":"Omics"},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib78","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbrc.2012.02.008","article-title":"Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility","volume":"419","author":"Lu","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib79","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.yexmp.2011.06.005","article-title":"Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome","volume":"91","author":"Luo","year":"2011","journal-title":"Exp. Mol. Pathol."},{"issue":"4","key":"10.1016\/j.yexcr.2017.10.018_bib80","first-page":"807","article-title":"The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis","volume":"63","author":"Luo","year":"2003","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib81","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000292542","article-title":"Plasma prealbumin in women with epithelial ovarian carcinoma","volume":"37","author":"Mahlck","year":"1994","journal-title":"Gynecol. Obstet. Invest."},{"issue":"6","key":"10.1016\/j.yexcr.2017.10.018_bib82","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/17425255.4.6.697","article-title":"Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily","volume":"4","author":"Marchitti","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"11","key":"10.1016\/j.yexcr.2017.10.018_bib83","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/gcc.22387","article-title":"Molecular bases of aberrant miR-182 expression in ovarian cancer","volume":"55","author":"Marzec-Kotarska","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"10.1016\/j.yexcr.2017.10.018_bib84","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/sj.onc.1209373","article-title":"Glutathione S-transferase polymorphisms: cancer incidence and therapy","volume":"25","author":"McIlwain","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2004.07.039","article-title":"Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma","volume":"95","author":"McIntosh","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.yexcr.2017.10.018_bib86","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.1120733109","article-title":"Human ovarian cancer stem\/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance","volume":"109","author":"Meirelles","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.yexcr.2017.10.018_bib87","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10585-012-9482-4","article-title":"CD44+\/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival","volume":"29","author":"Meng","year":"2012","journal-title":"Clin. Exp. Metastas."},{"issue":"40","key":"10.1016\/j.yexcr.2017.10.018_bib88","doi-asserted-by":"crossref","first-page":"15505","DOI":"10.1073\/pnas.0710686105","article-title":"Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer","volume":"105","author":"Miyahara","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"10.1016\/j.yexcr.2017.10.018_bib89","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/93.19.1458","article-title":"Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology","volume":"93","author":"Mok","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.yexcr.2017.10.018_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-387042-1.00001-0","article-title":"HE4 in ovarian cancer: from discovery to clinical application","volume":"55","author":"Montagnana","year":"2011","journal-title":"Adv. Clin. Chem."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib91","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"21","key":"10.1016\/j.yexcr.2017.10.018_bib92","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1073\/pnas.0502178102","article-title":"Serum protein markers for early detection of ovarian cancer","volume":"102","author":"Mor","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib93","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1447-0756.2006.00403.x","article-title":"Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer","volume":"32","author":"Nakae","year":"2006","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"11","key":"10.1016\/j.yexcr.2017.10.018_bib94","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.yexcr.2017.10.018_bib95","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9378(84)90444-7","article-title":"Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix","volume":"148","author":"Niloff","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.yexcr.2017.10.018_bib96","first-page":"2380","article-title":"Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients","volume":"7","author":"Obiezu","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.yexcr.2017.10.018_bib97","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1373\/clinchem.2005.049692","article-title":"Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids","volume":"51","author":"Obiezu","year":"2005","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib98","first-page":"63","article-title":"Mesothelin gene expression and promoter methylation\/hypomethylation in gynecological tumors","volume":"31","author":"Obulhasim","year":"2010","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib99","first-page":"1168","article-title":"Expression of nestin and CD133 in serous ovarian carcinoma","volume":"21","author":"Onisim","year":"2016","journal-title":"J. Buon"},{"issue":"11","key":"10.1016\/j.yexcr.2017.10.018_bib100","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/stem.1207","article-title":"Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation","volume":"30","author":"Paik","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.yexcr.2017.10.018_bib101","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bios.2015.05.051","article-title":"Multiplexed magnetic nanoparticle-antibody conjugates (MNPs-ABS) based prognostic detection of ovarian cancer biomarkers, CA-125, beta-2M and ApoA1 using fluorescence spectroscopy with comparison of surface plasmon resonance (SPR) analysis","volume":"73","author":"Pal","year":"2015","journal-title":"Biosens. Bioelectron."},{"issue":"14","key":"10.1016\/j.yexcr.2017.10.018_bib102","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/onc.2009.500","article-title":"Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer","volume":"29","author":"Peng","year":"2010","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.yexcr.2017.10.018_bib103","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1634\/stemcells.19-4-271","article-title":"Oct-4: gatekeeper in the beginnings of mammalian development","volume":"19","author":"Pesce","year":"2001","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib104","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1757-2215-1-4","article-title":"Ovarian cancer: emerging concept on cancer stem cells","volume":"1","author":"Ponnusamy","year":"2008","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib105","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160247","article-title":"NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer","volume":"37","author":"Qin","year":"2017","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib106","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0888-7543(05)80236-8","article-title":"Genomic organization of the human folate receptor genes on chromosome 11q13","volume":"14","author":"Ragoussis","year":"1992","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib107","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1530\/jrf.0.0930303","article-title":"Distribution of glutathione S-transferase isoenzymes in human ovary","volume":"93","author":"Rahilly","year":"1991","journal-title":"J. Reprod. Fertil."},{"key":"10.1016\/j.yexcr.2017.10.018_bib108","doi-asserted-by":"crossref","first-page":"475983","DOI":"10.1155\/2011\/475983","article-title":"Potential markers for detection and monitoring of ovarian cancer","volume":"2011","author":"Rein","year":"2011","journal-title":"J. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2008.08.036","article-title":"The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform","volume":"112","author":"Resnick","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2005.06.040","article-title":"Potential markers that complement expression of CA125 in epithelial ovarian cancer","volume":"99","author":"Rosen","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.yexcr.2017.10.018_bib111","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib112","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1996.14.5.1545","article-title":"Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125","volume":"14","author":"Rustin","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib113","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jog.13220","article-title":"Is serum level of nestin useful in detecting epithelial ovarian cancer?","volume":"43","author":"Sal","year":"2017","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib114","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yexcr.2005.01.018","article-title":"The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation","volume":"306","author":"Salceda","year":"2005","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1757-2215-5-37","article-title":"Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary","volume":"5","author":"Samardzija","year":"2012","journal-title":"J. Ovarian Res."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib116","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.1995.71","article-title":"Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer","volume":"71","author":"Scambia","year":"1995","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.yexcr.2017.10.018_bib117","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2217\/17520363.1.4.513","article-title":"CA125 in ovarian cancer","volume":"1","author":"Scholler","year":"2007","journal-title":"Biomark. Med."},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib118","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib119","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ygyno.2007.01.018","article-title":"Ovarian cancer specific kallikrein profile in effusions","volume":"105","author":"Shih","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.yexcr.2017.10.018_bib120","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib121","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ygyno.2007.03.035","article-title":"B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression","volume":"106","author":"Simon","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib122","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-04-3550","article-title":"B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer","volume":"66","author":"Simon","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.yexcr.2017.10.018_bib123","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1158\/0008-5472.CAN-08-2678","article-title":"Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis","volume":"69","author":"Slack-Davis","year":"2009","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.yexcr.2017.10.018_bib124","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/j.1349-7006.2008.00911.x","article-title":"Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K\/Akt pathway","volume":"99","author":"Song","year":"2008","journal-title":"Cancer Sci."},{"issue":"46","key":"10.1016\/j.yexcr.2017.10.018_bib125","doi-asserted-by":"crossref","first-page":"19997","DOI":"10.1073\/pnas.1009010107","article-title":"Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer","volume":"107","author":"Su","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib126","first-page":"851","article-title":"Microarray analysis of gene expression in the ovarian cancer cell line HO-8910 with silencing of the ZNF217 gene","volume":"2","author":"Sun","year":"2009","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yexcr.2017.10.018_bib127","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13048-016-0228-9","article-title":"The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer","volume":"9","author":"Tamir","year":"2016","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.yexcr.2017.10.018_bib128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13048-014-0109-z","article-title":"Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes","volume":"7","author":"Tamir","year":"2014","journal-title":"J. Ovarian Res."},{"issue":"10","key":"10.1016\/j.yexcr.2017.10.018_bib129","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2074::AID-CNCR27>3.0.CO;2-3","article-title":"The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells","volume":"86","author":"Tanimoto","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2004.09.020","article-title":"CA125 regression during neoadjuvant chemotherapy as an independent prognostic factor for survival in patients with advanced ovarian serous adenocarcinoma","volume":"96","author":"Tate","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"27","key":"10.1016\/j.yexcr.2017.10.018_bib131","doi-asserted-by":"crossref","first-page":"44312","DOI":"10.18632\/oncotarget.17871","article-title":"The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer","volume":"8","author":"Tayama","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.yexcr.2017.10.018_bib132","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2005.08.060","article-title":"B7-H4 overexpression in ovarian tumors","volume":"100","author":"Tringler","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib133","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/01.ATV.0000122854.76267.5c","article-title":"Signaling in leukocyte transendothelial migration","volume":"24","author":"van Buul","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib134","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the risk of ovarian malignancy algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13346-012-0095-x","article-title":"Cancer stem cells and therapeutic targets: an emerging field for cancer treatment","volume":"3","author":"Vaz","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.yexcr.2017.10.018_bib136","doi-asserted-by":"crossref","first-page":"34730","DOI":"10.1038\/srep34730","article-title":"Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer","volume":"6","author":"Virant-Klun","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.yexcr.2017.10.018_bib137","first-page":"775","article-title":"Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix","volume":"8","author":"Wu","year":"1999","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib138","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/onc.2013.537","article-title":"Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer","volume":"34","author":"Xiang","year":"2015","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib139","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2008.12.004","article-title":"EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem\/progenitor cell features","volume":"136","author":"Yamashita","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2017.10.018_bib140","doi-asserted-by":"crossref","first-page":"e995","DOI":"10.1038\/cddis.2013.523","article-title":"Prostasin may contribute to chemoresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP\/PAK2-p34\/actin","volume":"5","author":"Yan","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2017.10.018_bib141","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2407-10-133","article-title":"Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma","volume":"10","author":"Yang","year":"2010","journal-title":"BMC Cancer"},{"issue":"22","key":"10.1016\/j.yexcr.2017.10.018_bib142","first-page":"3497","article-title":"The identification of the biological characteristics of human ovarian cancer stem cells","volume":"18","author":"Yan","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.yexcr.2017.10.018_bib143","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: mir-214 induces cell survival and cisplatin resistance by targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.yexcr.2017.10.018_bib144","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5301\/JBM.2011.8551","article-title":"Is CD133 a biomarker for cancer stem cells of colorectal cancer and brain tumors? A meta-analysis","volume":"26","author":"Yang","year":"2011","journal-title":"Int. J. Biol. Mark."},{"issue":"10","key":"10.1016\/j.yexcr.2017.10.018_bib145","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.humpath.2009.02.013","article-title":"Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions","volume":"40","author":"Yuan","year":"2009","journal-title":"Hum. Pathol."},{"issue":"13","key":"10.1016\/j.yexcr.2017.10.018_bib146","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2008.19.2484","article-title":"Development of a multimarker assay for early detection of ovarian cancer","volume":"28","author":"Yurkovetsky","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.yexcr.2017.10.018_bib147","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.yexcr.2017.10.018_bib148","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.3892\/ol.2016.4527","article-title":"miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2","volume":"11","author":"Zhao","year":"2016","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.yexcr.2017.10.018_bib149","doi-asserted-by":"crossref","first-page":"e77853","DOI":"10.1371\/journal.pone.0077853","article-title":"Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2017.10.018_bib150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/med-2017-0007","article-title":"Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma","volume":"12","author":"Zheng","year":"2017","journal-title":"Open Med."},{"issue":"5","key":"10.1016\/j.yexcr.2017.10.018_bib151","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ncb1869","article-title":"Production of offspring from a germline stem cell line derived from neonatal ovaries","volume":"11","author":"Zou","year":"2009","journal-title":"Nat. Cell Biol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717305669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717305669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T20:26:24Z","timestamp":1719519984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482717305669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0014482717305669"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.10.018","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells \u2013 An updated review","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}